Encompass Health (EHC)
Encompass Health on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as services-hospitals.
3.5M
Short interest
settlement 2026-09-30
3.5
Days to cover
-0.6 days vs prior
72.3%
Short share of volume
2026-10-23
2
Fails to deliver
settlement 2026-09-30
Wed 28 Oct
Next earnings
estimated date
-$26.4M
Insider flow, 90 days
0 buys, 6 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in EHC is 3,488,343 shares, up 247,739 shares over the last month. Over the last 48 readings it ranged from 844,312 shares (13 June 2025) to 4,301,775 shares (30 January 2026). At the reported average volume of 982K shares a day that is 3.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ehc" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 3,488,343 | +16.3% | 981,872 | 3.55 |
| 2026-09-15 | 3,000,467 | -7.4% | 728,906 | 4.12 |
| 2026-08-31 | 3,240,604 | -1.0% | 873,315 | 3.71 |
| 2026-08-14 | 3,274,646 | -10.4% | 1,155,109 | 2.83 |
| 2026-07-31 | 3,653,920 | -6.7% | 747,174 | 4.89 |
| 2026-07-15 | 3,917,662 | +26.3% | 1,072,732 | 3.65 |
| 2026-06-30 | 3,103,037 | -1.4% | 1,428,186 | 2.17 |
| 2026-06-15 | 3,145,536 | -6.5% | 823,121 | 3.82 |
| 2026-05-29 | 3,365,633 | -1.3% | 714,363 | 4.71 |
| 2026-05-15 | 3,409,294 | +0.0% | 1,037,100 | 3.29 |
| 2026-04-30 | 3,408,607 | +11.6% | 958,480 | 3.56 |
| 2026-04-15 | 3,053,532 | -9.1% | 1,099,824 | 2.78 |
| 2026-03-31 | 3,360,743 | -4.9% | 857,337 | 3.92 |
| 2026-03-13 | 3,533,713 | -0.5% | 958,775 | 3.69 |
| 2026-02-27 | 3,549,962 | -6.7% | 989,674 | 3.59 |
| 2026-02-13 | 3,803,287 | -11.6% | 2,092,886 | 1.82 |
| 2026-01-30 | 4,301,775 | +23.8% | 1,156,420 | 3.72 |
| 2026-01-15 | 3,473,650 | -0.2% | 1,205,686 | 2.88 |
| 2025-12-31 | 3,479,262 | +19.7% | 992,778 | 3.50 |
| 2025-12-15 | 2,907,146 | +13.9% | 1,036,077 | 2.81 |
| 2025-11-28 | 2,552,732 | -3.5% | 603,848 | 4.23 |
| 2025-11-14 | 2,644,803 | +35.2% | 835,123 | 3.17 |
| 2025-10-31 | 1,956,680 | +18.1% | 974,461 | 2.01 |
| 2025-10-15 | 1,656,513 | -4.9% | 644,114 | 2.57 |
| 2025-09-30 | 1,742,239 | +19.1% | 591,060 | 2.95 |
| 2025-09-15 | 1,463,322 | +13.7% | 590,927 | 2.48 |
| 2025-08-29 | 1,286,815 | +25.1% | 713,593 | 1.80 |
| 2025-08-15 | 1,028,940 | +6.1% | 995,975 | 1.03 |
| 2025-07-31 | 969,386 | -2.0% | 962,299 | 1.01 |
| 2025-07-15 | 988,914 | -7.0% | 1,116,111 | 1.00 |
| 2025-06-30 | 1,062,743 | +25.9% | 716,465 | 1.48 |
| 2025-06-13 | 844,312 | -3.9% | 590,108 | 1.43 |
| 2025-05-30 | 878,401 | -27.7% | 637,380 | 1.38 |
| 2025-05-15 | 1,214,677 | -35.4% | 799,688 | 1.52 |
| 2025-04-30 | 1,881,174 | -24.7% | 1,314,715 | 1.43 |
| 2025-04-15 | 2,499,331 | +14.7% | 1,041,155 | 2.40 |
| 2025-03-31 | 2,179,410 | +5.0% | 595,299 | 3.66 |
| 2025-03-14 | 2,076,615 | -1.8% | 862,368 | 2.41 |
| 2025-02-28 | 2,114,345 | +19.5% | 655,007 | 3.23 |
| 2025-02-14 | 1,769,554 | +18.6% | 755,895 | 2.34 |
| 2025-01-31 | 1,492,326 | -19.4% | 636,223 | 2.35 |
| 2025-01-15 | 1,850,695 | +36.8% | 579,339 | 3.19 |
| 2024-12-31 | 1,353,327 | +6.7% | 632,426 | 2.14 |
| 2024-12-13 | 1,268,196 | +17.3% | 601,806 | 2.11 |
| 2024-11-29 | 1,081,028 | -2.1% | 609,165 | 1.77 |
| 2024-11-15 | 1,103,866 | +8.1% | 670,239 | 1.65 |
| 2024-10-31 | 1,021,176 | -15.3% | 831,062 | 1.23 |
| 2024-10-15 | 1,205,661 | -30.6% | 406,464 | 2.97 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of EHC volume is 72.3%, up 7.1 points over the last five sessions. Over the last 30 readings it ranged from 38.5% (13 October 2026) to 79.1% (14 September 2026). The latest reading is 14.7 points above the 30-session average of 57.6%, on 279K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 201K | 279K | 72.3% | 0 |
| 2026-10-22 | 288K | 478K | 60.3% | 3,800 |
| 2026-10-21 | 206K | 370K | 55.7% | 0 |
| 2026-10-20 | 321K | 612K | 52.4% | 0 |
| 2026-10-19 | 316K | 721K | 43.9% | 0 |
| 2026-10-16 | 218K | 334K | 65.2% | 150 |
| 2026-10-15 | 334K | 542K | 61.6% | 3,118 |
| 2026-10-14 | 161K | 303K | 53.1% | 0 |
| 2026-10-13 | 98K | 254K | 38.5% | 0 |
| 2026-10-12 | 188K | 360K | 52.2% | 0 |
| 2026-10-09 | 162K | 266K | 60.7% | 0 |
| 2026-10-08 | 172K | 300K | 57.4% | 0 |
| 2026-10-07 | 220K | 358K | 61.4% | 181 |
| 2026-10-06 | 321K | 501K | 64.1% | 0 |
| 2026-10-05 | 207K | 294K | 70.4% | 0 |
| 2026-10-02 | 200K | 411K | 48.7% | 0 |
| 2026-10-01 | 134K | 247K | 54.3% | 192 |
| 2026-09-30 | 122K | 214K | 56.8% | 0 |
| 2026-09-29 | 227K | 419K | 54.2% | 0 |
| 2026-09-28 | 200K | 400K | 50.0% | 0 |
| 2026-09-25 | 180K | 321K | 56.0% | 0 |
| 2026-09-24 | 165K | 297K | 55.6% | 1,549 |
| 2026-09-23 | 150K | 376K | 39.9% | 402 |
| 2026-09-22 | 244K | 410K | 59.5% | 0 |
| 2026-09-21 | 189K | 277K | 68.3% | 42 |
| 2026-09-18 | 147K | 318K | 46.4% | 0 |
| 2026-09-17 | 229K | 296K | 77.5% | 10,144 |
| 2026-09-16 | 189K | 333K | 56.8% | 86 |
| 2026-09-15 | 172K | 306K | 56.3% | 0 |
| 2026-09-14 | 219K | 277K | 79.1% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 September 2026, the fails-to-deliver balance in EHC is 2 shares, down 189 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (10 September 2026) to 26,282 shares (18 May 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-30 | 2 | $123.56 | $247 |
| 2026-09-15 | 191 | $122.53 | $23K |
| 2026-09-14 | 8 | $121.71 | $974 |
| 2026-09-10 | 1 | $121.52 | $122 |
| 2026-09-01 | 3,446 | $120.21 | $414K |
| 2026-08-27 | 327 | $120.78 | $39K |
| 2026-08-19 | 35 | $122.10 | $4K |
| 2026-08-14 | 21 | $123.55 | $3K |
| 2026-08-07 | 14 | $124.82 | $2K |
| 2026-08-06 | 14 | $110.90 | $2K |
| 2026-07-08 | 280 | $110.72 | $31K |
| 2026-07-07 | 59 | $106.99 | $6K |
| 2026-06-02 | 5 | $102.73 | $514 |
| 2026-05-26 | 368 | $104.96 | $39K |
| 2026-05-18 | 26,282 | $106.64 | $2.8M |
| 2026-05-08 | 3,250 | $107.15 | $348K |
| 2026-05-04 | 6 | $107.48 | $645 |
| 2026-05-01 | 8,713 | $100.00 | $871K |
| 2026-04-27 | 189 | $101.98 | $19K |
| 2026-04-22 | 221 | $102.77 | $23K |
| 2026-04-08 | 3 | $105.67 | $317 |
| 2026-03-26 | 1,082 | $98.82 | $107K |
| 2026-03-17 | 84 | $101.43 | $9K |
| 2026-03-13 | 15,625 | $100.30 | $1.6M |
| 2026-03-11 | 1,687 | $106.89 | $180K |
| 2026-03-09 | 26,166 | $106.95 | $2.8M |
| 2026-03-04 | 5,644 | $108.01 | $610K |
| 2026-03-03 | 3,800 | $108.06 | $411K |
| 2026-02-24 | 7,858 | $106.15 | $834K |
| 2026-02-23 | 353 | $106.55 | $38K |
Insider trades
SEC Form 4, newest first. JSONInsiders at EHC reported 6 open-market sells worth $26.4M in the last 90 days and no open-market buys. Latest filing: Reidy Christopher R (Director) on 2026-10-19.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Reidy Christopher R | Director | Grant | 284 | $126.89 | $36K | 18K |
| 2026-10-19 | Christie Edward M III | Director | Grant | 221 | $126.63 | $28K | 10K |
| 2026-10-15 | Williams Terrance | Director | Grant | 28 | $0.00 | $0 | 17K |
| 2026-10-15 | CARMICHAEL GREG D | Director | Grant | 28 | $0.00 | $0 | 20K |
| 2026-10-15 | KATZ LESLYE G | Director | Grant | 81 | $0.00 | $0 | 50K |
| 2026-10-15 | O'Connor Kevin J. | Director | Grant | 18 | $0.00 | $0 | 12K |
| 2026-10-15 | Hayes Cain A | Director | Grant | 4 | $0.00 | $0 | 2K |
| 2026-10-15 | Reidy Christopher R | Director | Grant | 20 | $0.00 | $0 | 18K |
| 2026-10-15 | Christie Edward M III | Director | Grant | 11 | $0.00 | $0 | 9K |
| 2026-10-15 | HERMAN JOAN E | Director | Grant | 81 | $0.00 | $0 | 50K |
| 2026-10-15 | SCHLICHTING NANCY M | Director | Grant | 38 | $0.00 | $0 | 23K |
| 2026-08-31 | Price Andrew L | Chief Accounting Officer | Sell | 5K | $120.93 | $630K | 69K |
| 2026-08-31 | Darby John Patrick | EVP, Gen Counsel & Secretary | Sell | 5K | $121.09 | $588K | 75K |
| 2026-08-31 | Darby John Patrick | EVP, Gen Counsel & Secretary | Exercise or conversion | 5K | $35.06 | $170K | 80K |
| 2026-08-10 | Tarr Mark J | President & CEO | Sell | 2K | $126.06 | $199K | 268K |
| 2026-08-10 | Tarr Mark J | President & CEO | Sell | 172K | $125.46 | $21.5M | 269K |
| 2026-08-10 | Darby John Patrick | EVP, Gen Counsel & Secretary | Sell | 9K | $125.95 | $1.1M | 75K |
| 2026-08-10 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Sell | 19K | $125.38 | $2.4M | 51K |
| 2026-07-16 | Reidy Christopher R | Director | Grant | 319 | $112.40 | $36K | 18K |
| 2026-07-16 | Christie Edward M III | Director | Grant | 248 | $112.43 | $28K | 9K |
| 2026-07-15 | Reidy Christopher R | Director | Grant | 21 | $0.00 | $0 | 17K |
| 2026-07-15 | Williams Terrance | Director | Grant | 29 | $0.00 | $0 | 17K |
| 2026-07-15 | SCHLICHTING NANCY M | Director | Grant | 40 | $0.00 | $0 | 23K |
| 2026-07-15 | O'Connor Kevin J. | Director | Grant | 19 | $0.00 | $0 | 12K |
| 2026-07-15 | KATZ LESLYE G | Director | Grant | 85 | $0.00 | $0 | 50K |
| 2026-07-15 | HERMAN JOAN E | Director | Grant | 85 | $0.00 | $0 | 50K |
| 2026-07-15 | Hayes Cain A | Director | Grant | 4 | $0.00 | $0 | 2K |
| 2026-07-15 | Christie Edward M III | Director | Grant | 11 | $0.00 | $0 | 9K |
| 2026-07-15 | CARMICHAEL GREG D | Director | Grant | 29 | $0.00 | $0 | 20K |
| 2026-05-15 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Sell | 1 | $107.28 | $107 | 69K |
| 2026-05-15 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Sell | 28K | $106.83 | $3.0M | 69K |
| 2026-05-15 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Exercise or conversion | 28K | $32.94 | $912K | 97K |
| 2026-05-11 | Tuer Patrick William | EVP, Chief Operating Officer | Sell | 682 | $104.56 | $71K | 25K |
| 2026-05-07 | O'Connor Kevin J. | Director | Grant | 2K | $0.00 | $0 | 12K |
| 2026-05-07 | Reidy Christopher R | Director | Grant | 2K | $0.00 | $0 | 17K |
| 2026-05-07 | Hayes Cain A | Director | Grant | 2K | $0.00 | $0 | 2K |
| 2026-05-07 | Williams Terrance | Director | Grant | 2K | $0.00 | $0 | 17K |
| 2026-05-07 | KATZ LESLYE G | Director | Grant | 2K | $0.00 | $0 | 50K |
| 2026-05-07 | HERMAN JOAN E | Director | Grant | 2K | $0.00 | $0 | 50K |
| 2026-05-07 | SCHLICHTING NANCY M | Director | Grant | 2K | $0.00 | $0 | 23K |
| 2026-05-07 | Christie Edward M III | Director | Grant | 2K | $0.00 | $0 | 9K |
| 2026-05-07 | CARMICHAEL GREG D | Director | Grant | 2K | $0.00 | $0 | 20K |
| 2026-04-16 | Reidy Christopher R | Director | Grant | 334 | $106.48 | $36K | 16K |
| 2026-04-16 | Christie Edward M III | Director | Grant | 261 | $106.17 | $28K | 7K |
| 2026-04-15 | Hayes Cain A | Director | Grant | 1 | $0.00 | $0 | 458 |
| 2026-04-15 | HERMAN JOAN E | Director | Grant | 85 | $0.00 | $0 | 48K |
| 2026-04-15 | KATZ LESLYE G | Director | Grant | 85 | $0.00 | $0 | 48K |
| 2026-04-15 | O'Connor Kevin J. | Director | Grant | 17 | $0.00 | $0 | 10K |
| 2026-04-15 | Reidy Christopher R | Director | Grant | 19 | $0.00 | $0 | 15K |
| 2026-04-15 | SCHLICHTING NANCY M | Director | Grant | 39 | $0.00 | $0 | 21K |
| 2026-04-15 | Williams Terrance | Director | Grant | 27 | $0.00 | $0 | 15K |
| 2026-04-15 | Christie Edward M III | Director | Grant | 9 | $0.00 | $0 | 7K |
| 2026-04-15 | CARMICHAEL GREG D | Director | Grant | 27 | $0.00 | $0 | 19K |
| 2026-03-09 | Fay Edmund | Sr. Vice Pres. and Treasurer | Gift | 3K | $0.00 | $0 | 86K |
| 2026-03-09 | Fay Edmund | Sr. Vice Pres. and Treasurer | Sell | 12K | $107.00 | $1.3M | 89K |
| 2026-02-28 | Price Andrew L | Chief Accounting Officer | Tax withholding | 307 | $107.88 | $33K | 75K |
| 2026-02-28 | Fay Edmund | Sr. Vice Pres. and Treasurer | Tax withholding | 280 | $107.88 | $30K | 101K |
| 2026-02-28 | Tarr Mark J | President & CEO | Tax withholding | 2K | $107.88 | $236K | 441K |
| 2026-02-28 | Tuer Patrick William | EVP, Chief Operating Officer | Tax withholding | 545 | $107.88 | $59K | 25K |
| 2026-02-28 | Darby John Patrick | EVP, Gen Counsel & Secretary | Tax withholding | 416 | $107.88 | $45K | 84K |
| 2026-02-28 | Charbonneau Elissa Joy | Chief Medical Officer | Tax withholding | 369 | $107.88 | $40K | 18K |
| 2026-02-28 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Tax withholding | 776 | $107.88 | $84K | 69K |
| 2026-02-23 | Tarr Mark J | President & CEO | Tax withholding | 2K | $106.15 | $264K | 443K |
| 2026-02-23 | Fay Edmund | Sr. Vice Pres. and Treasurer | Tax withholding | 380 | $106.15 | $40K | 102K |
| 2026-02-23 | Tuer Patrick William | EVP, Chief Operating Officer | Tax withholding | 506 | $106.15 | $54K | 26K |
| 2026-02-23 | Price Andrew L | Chief Accounting Officer | Tax withholding | 404 | $106.15 | $43K | 75K |
| 2026-02-23 | Darby John Patrick | EVP, Gen Counsel & Secretary | Tax withholding | 7K | $106.15 | $742K | 84K |
| 2026-02-23 | Charbonneau Elissa Joy | Chief Medical Officer | Tax withholding | 440 | $106.15 | $47K | 18K |
| 2026-02-23 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Tax withholding | 15K | $106.15 | $1.6M | 70K |
| 2026-02-20 | Tarr Mark J | President & CEO | Tax withholding | 2K | $106.55 | $191K | 446K |
| 2026-02-20 | Fay Edmund | Sr. Vice Pres. and Treasurer | Tax withholding | 208 | $106.55 | $22K | 102K |
| 2026-02-20 | Price Andrew L | Chief Accounting Officer | Tax withholding | 228 | $106.55 | $24K | 75K |
| 2026-02-20 | Tuer Patrick William | EVP, Chief Operating Officer | Tax withholding | 405 | $106.55 | $43K | 26K |
| 2026-02-20 | Darby John Patrick | EVP, Gen Counsel & Secretary | Tax withholding | 328 | $106.55 | $35K | 91K |
| 2026-02-20 | Charbonneau Elissa Joy | Chief Medical Officer | Tax withholding | 287 | $106.55 | $31K | 18K |
| 2026-02-20 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Tax withholding | 674 | $106.55 | $72K | 85K |
| 2026-02-19 | Price Andrew L | Chief Accounting Officer | Grant | 2K | $0.00 | $0 | 79K |
| 2026-02-19 | Tarr Mark J | President & CEO | Grant | 13K | $0.00 | $0 | 491K |
| 2026-02-19 | Fay Edmund | Sr. Vice Pres. and Treasurer | Grant | 1K | $0.00 | $0 | 106K |
| 2026-02-19 | Tuer Patrick William | EVP, Chief Operating Officer | Grant | 4K | $0.00 | $0 | 30K |
| 2026-02-19 | Darby John Patrick | EVP, Gen Counsel & Secretary | Grant | 2K | $0.00 | $0 | 100K |
| 2026-02-19 | Charbonneau Elissa Joy | Chief Medical Officer | Grant | 2K | $0.00 | $0 | 23K |
| 2026-02-19 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Grant | 4K | $0.00 | $0 | 102K |
| 2026-02-19 | Tarr Mark J | President & CEO | Tax withholding | 43K | $107.15 | $4.6M | 447K |
| 2026-02-19 | Fay Edmund | Sr. Vice Pres. and Treasurer | Tax withholding | 3K | $107.15 | $373K | 102K |
| 2026-02-19 | Price Andrew L | Chief Accounting Officer | Tax withholding | 4K | $107.15 | $396K | 76K |
| 2026-02-19 | Tuer Patrick William | EVP, Chief Operating Officer | Tax withholding | 3K | $107.15 | $342K | 27K |
| 2026-02-19 | Darby John Patrick | EVP, Gen Counsel & Secretary | Tax withholding | 8K | $107.15 | $847K | 92K |
| 2026-02-19 | Charbonneau Elissa Joy | Chief Medical Officer | Tax withholding | 4K | $107.15 | $430K | 19K |
| 2026-02-19 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Tax withholding | 17K | $107.15 | $1.8M | 86K |
| 2026-02-18 | Price Andrew L | Chief Accounting Officer | Grant | 8K | $0.00 | $0 | 78K |
| 2026-02-18 | Tarr Mark J | President & CEO | Grant | 101K | $0.00 | $0 | 478K |
| 2026-02-18 | Fay Edmund | Sr. Vice Pres. and Treasurer | Grant | 8K | $0.00 | $0 | 104K |
| 2026-02-18 | Tuer Patrick William | EVP, Chief Operating Officer | Grant | 10K | $0.00 | $0 | 26K |
| 2026-02-18 | Darby John Patrick | EVP, Gen Counsel & Secretary | Grant | 18K | $0.00 | $0 | 97K |
| 2026-02-18 | Charbonneau Elissa Joy | Chief Medical Officer | Grant | 9K | $0.00 | $0 | 21K |
| 2026-02-18 | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | Grant | 38K | $0.00 | $0 | 98K |
| 2026-02-11 | Tarr Mark J | President & CEO | Sell | 213 | $113.58 | $24K | 377K |
| 2026-02-11 | Tarr Mark J | President & CEO | Sell | 88K | $113.09 | $9.9M | 377K |
| 2026-02-11 | Tarr Mark J | President & CEO | Sell | 6K | $111.89 | $678K | 465K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON8 Form 144 notices on file for EHC worth $45.9M at the prices reported; 4 in the last 90 days worth $25.8M. Latest: John Patrick Darby filed on 2026-08-31 to sell 4,858 shares ($588K) from 2026-08-31.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-31 | John Patrick DarbyOfficer | 5K | $588K | 0.005% | 2026-08-31 | UBS Financial Services Inc |
| 2026-08-10 | Mark TarrOfficer | 173K | $21.7M | 0.176% | 2026-08-10 | UBS Financial Services Inc |
| 2026-08-10 | John Patrick DarbyOfficer | 9K | $1.1M | 0.009% | 2026-08-10 | UBS Financial Services Inc |
| 2026-08-10 | Douglas ColtharpOfficer | 19K | $2.4M | 0.019% | 2026-08-10 | UBS Financial Services Inc |
| 2026-05-15 | Douglas Edward ColtharpOfficer | 28K | $3.0M | 0.028% | 2026-05-15 | UBS Financial Services Inc |
| 2026-05-11 | Patrick TuerOfficer | 682 | $71K | 0.001% | 2026-05-11 | UBS Financial Services Inc |
| 2026-02-11 | Mark TarrOfficer | 150K | $16.7M | 0.149% | 2026-02-11 | UBS Financial Services Inc |
| 2026-02-10 | Patrick TuerOfficer | 3K | $302K | 0.003% | 2026-02-10 | UBS Financial Services Inc |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of EHC in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 5.3% of the class (5,233,622 shares), filed 2026-04-29 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G | T. Rowe Price Associates, Inc.investment adviser | 5.1M | 5.1% | 2026-06-30 |
| 2026-07-31 | 13G/Ano. 1 | Vanguard Portfolio Managementinvestment adviser | 4.9M | 5.0% | 2026-06-30 |
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 5.2M | 5.3% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 13 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-12 | 13G/Ano. 1 | Invesco Ltd.parent holding company, investment adviser | 5.0M | 4.9% | 2025-12-31 |
13F holders
Tracked managers holding EHC at their latest 13F. JSON7 of the 30 tracked managers held EHC at their latest 13F, $687.0M in total at quarter-end prices. Citadel Advisors is the largest at $259.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 2.6M | $259.1M | 0.03% | +2.1M |
| Two Sigma Investments | 2026-06-30 | 2.3M | $229.2M | 0.17% | +46K |
| Millennium Management | 2026-06-30 | 806K | $81.4M | 0.03% | +328K |
| AQR Capital Management | 2026-06-30 | 562K | $56.6M | 0.02% | +61K |
| D. E. Shaw & Co. | 2026-06-30 | 385K | $38.9M | 0.02% | -181K |
| Renaissance Technologies | 2026-06-30 | 175K | $17.6M | 0.02% | -91K |
| Bridgewater Associates | 2026-06-30 | 41K | $4.1M | 0.02% | -5K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Encompass Health reported revenue of $1.60B, up 9.6% from the same quarter a year earlier, and net income of $153.9M (1.54 diluted EPS). In FY 2025 it reported and spent $158.0M on buybacks and $71.1M on dividends.
- Cash
- $107.7M
- Equity
- $2.60B
- Total assets
- $7.46B
- Shares outstanding
- 98,653,384
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $1.60B | $153.9M | 9.6% | 1.54 |
| Q1 FY 2026 | 2026-03-31 | $1.59B | $194.5M | 12.3% | 1.93 |
| Q4 FY 2025derived | 2025-12-31 | $1.54B | $146.1M | 9.5% | n/a |
| Q3 FY 2025 | 2025-09-30 | $1.48B | $126.5M | 8.6% | 1.24 |
| Q2 FY 2025 | 2025-06-30 | $1.46B | $142.1M | 9.7% | 1.39 |
| Q1 FY 2025 | 2025-03-31 | $1.46B | $151.5M | 10.4% | 1.48 |
| Q4 FY 2024derived | 2024-12-31 | $1.41B | $120.9M | 8.6% | n/a |
| Q3 FY 2024 | 2024-09-30 | $1.35B | $108.2M | 8.0% | 1.06 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5.94B | $566.2M | n/a | $736.4M | $158.0M | $71.1M |
| FY 2024 | 2024-12-31 | $5.37B | $455.7M | n/a | $642.5M | $31.1M | $62.8M |
| FY 2023 | 2023-12-31 | $4.80B | $352.0M | n/a | $583.1M | $0 | $60.4M |
| FY 2022 | 2022-12-31 | $4.35B | $271.0M | $705.8M | $564.8M | $0 | $99.0M |
| FY 2021 | 2021-12-31 | $4.01B | $412.2M | $715.8M | $524.6M | $0 | $112.2M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-28 from the cover page.
What this page is
Encompass Health in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Encompass Health (EHC), SEC CIK 785161, listed on NYSE, classified by the SEC as services-hospitals. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-31.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-19.JSON and CSV
- Company record
- EDGAR filing index for CIK 785161Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-hospitals
Other company pages
- MLMMartin Marietta Materials
- MMM3M
- MNSTMonster Beverage
- MOAltria Group
- MODModine Manufacturing
- MOSMosaic
- MPMP Materials
- MPCMarathon Petroleum
- MPWRMonolithic Power Systems
- MRKMerck
- MRNAModerna
- MRSHMarsh & McLennan Companies
- MRVLMarvell Technology
- MSMorgan Stanley
- MSCIMSCI
- MSFTMicrosoft
- MSIMotorola Solutions
- MSTRStrategy
- MTBM&T Bank
- MTCHMatch Group
- MTDMettler-Toledo International
- MTNVail Resorts
- MTSIMACOM Technology Solutions Holdings
Datasets
Frequently Asked Questions
How much of EHC is sold short?
3,488,343 shares were held short at the 2026-09-30 settlement, 3.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is EHC's daily short volume?
On 2026-10-23, 201,440 of the 278,658 EHC shares reported to FINRA were sold short, 72.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does EHC have fails to deliver?
The SEC's latest file shows 2 EHC shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.
Are EHC insiders buying or selling?
Insiders at EHC reported 6 open-market sells worth $26.4M in the last 90 days and no open-market buys. Latest filing: Reidy Christopher R (Director) on 2026-10-19.
Have EHC insiders filed to sell?
8 Form 144 notices on file for EHC worth $45.9M at the prices reported; 4 in the last 90 days worth $25.8M. Latest: John Patrick Darby filed on 2026-08-31 to sell 4,858 shares ($588K) from 2026-08-31.
Who owns 5% or more of EHC?
2 holders report 5% or more of EHC in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 5.3% of the class (5,233,622 shares), filed 2026-04-29 for an event on 2026-03-31.
What did EHC report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Encompass Health reported revenue of $1.60B, up 9.6% from the same quarter a year earlier, and net income of $153.9M (1.54 diluted EPS). In FY 2025 it reported and spent $158.0M on buybacks and $71.1M on dividends.
Which tracked 13F managers own EHC?
7 of the 30 tracked 13F managers held EHC shares at their latest filing, $687.0M in all. The largest: Ken Griffin's Citadel Advisors (2.6M shares, $259.1M), Two Sigma Investments (2.3M shares, $229.2M), Izzy Englander's Millennium Management (806K shares, $81.4M), Cliff Asness's AQR Capital Management (562K shares, $56.6M), D. E. Shaw & Co. (385K shares, $38.9M), Renaissance Technologies (175K shares, $17.6M). The table above lists all 7.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.